A phase 2 trial assesses fixed-duration epcoritamab monotherapy as first-line therapy for frail older adults with newly diagnosed anthracycline-ineligible large B-cell lymphoma.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/epcoritamab-shows-promise-frail-older-adults-lbcl-2026a1000mma?src=rss
Author :
Publish date : 2026-07-03 09:15:00
Copyright for syndicated content belongs to the linked Source.